Idorsia has extended its cash runway into 2025 via an exclusivity fee for global rights negotiations for Tryvio.
In an advancement for diabetes management, the US Food and Drug Administration (FDA) has granted clearance to Medtronic’s new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback